Publications by authors named "Chen Benchao"

Claim this Profile
S
Safety, Pharmacokinetics, and Pharmacodynamics Evaluation of Ivonescimab, a Novel Bispecific Antibody Targeting PD-1 and VEGF, in Chinese Patients With Advanced Solid Tumors.
Fenghua Wang, Xiaoli Wei, Yulong Zheng, Jing Wang, Jieer Ying, Benchao Chen

Cancer Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab.
Yanyan Zhang, Zhaohui Pei, Beijian Chen, Yanling Qu, Xiaolin Dong, Benchao Chen

Pharmacol Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated RNA expression and alternative polyadenylation analysis identified CPSF1-CCDC137 oncogenic axis in lung adenocarcinoma.
Xiang Xudong, Li Heng, Chen Benchao, Chen Wenjie, Lei Bao

Environ Toxicol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel tumor mutation-related long non-coding RNA signature for predicting overall survival and immunotherapy response in lung adenocarcinoma.
Wenjie Chen, Chen Liao, Xudong Xiang, Heng Li, Qiang Wu, Benchao Chen

Heliyon· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serplulimab monotherapy in extensive-stage small-cell lung cancer with brain metastasis: a case report.
Xudong Xiang, Heng Li, Bao Lei, Benchao Chen, Gaofeng Li

Immunotherapy· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Pharmacokinetics and Preliminary Efficacy of IL4-Rα Monoclonal Antibody AK120 in Both Healthy and Atopic Dermatitis Subjects: A Phase I, Randomized, Two-Part, Double-Blind, Placebo-Controlled, Dose-Escalation, First-In-Human Clinical Study.
Christopher John Wynne, Alexandra Cole, Charlotte Lemech, Guoqin Wang, Yu Zhang, Benchao Chen

Dermatol Ther (Heidelb)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety and Pharmacokinetics of IL-17 Monoclonal Antibody Injection (AK111) in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blinded, Placebo-Controlled Phase Ib Multidose Escalation Clinical Study.
Congjun Jiang, Huan Zhou, Wanlu Zhang, Yu Xia, Baiyong Li, Benchao Chen

Dermatol Ther (Heidelb)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic/pharmacodynamic analysis of AK111, an IL-17A monoclonal antibody, in subjects with moderate-to-severe plaque psoriasis.
Qian Li, Ju Qiao, Hongzhong Jin, Benchao Chen, Zhimei He

Front Pharmacol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of the common tumour-infiltrating lymphocyte subtypes for patients with non-small cell lung cancer: A meta-analysis.
Benchao Chen, Heng Li, Chao Liu, Xudong Xiang, Shuting Wang

PLoS One· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential prognostic value of delta-like protein 3 in small cell lung cancer: a meta-analysis.
Benchao Chen, Heng Li, Chao Liu, Shuting Wang, Feiyue Zhang

World J Surg Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[In vitro comparison of transdermal characteristics of xiaoyu ointment and xiaoyu plaster].
Chuncheng Zhu, Liping Peng, Benchao Chen, Qun He, Qingbo Wen

Zhongguo Zhong Yao Za Zhi· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis